Tyler Merkeley, CARB-X co-founder and program director for ASPR’s Biomedical Advanced Research and Development Authority, describes the drivers and next steps in creating a diverse portfolio Powered by CARB-X, one of the world’s largest public-private partnerships dedicated to accelerating development of innovative antibacterial drugs, diagnostics, and devices.
Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens.
Application Due Date: October 3, 2016
Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in the first year of the award for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling $1,050,000 direct costs.
Total Award: ~4,000,000 over 5 years
To discuss this opportunity or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!
Purpose: NSF’s SBIR and STTR programs provide non-dilutive funds for early-stage research and development (R&D) at small businesses. This R&D should be based on innovative, transformational technology with potential for substantial commercial and/or societal benefits. The programs invite proposals from small businesses across a broad range of science and engineering disciplines. For the STTR program, this must be in collaboration with researchers at universities, Federally-Funded Research and Development Centers, and other non-profit institutions.
Application Due Dates:
SBIR Phase I Proposal: June 16, 2016
STTR Phase I Proposal: June 20, 2016
Budget: $225,000 for a 6-12 month development/ feasibility project. You can then compete for a second grant of up to $750,000 over a 2 year period, with the aim of advancing the technology toward commercial deployment.
Biological Technologies (BT)
- BT3. Life Sciences Research Tools
- BT4. Bioinstrumentation
- BT7. Computational Biology and Bioinformatics
- BT8. Advanced Biomanufacturing- New Topic
- BT9. Advanced technologies for functional genomics in organismal systems – New Topic
- Tissue Engineering and Regenerative Medicine
Smart Health (SH) and Biomedical (BM) Technologies
- SH1. Business Models for User-Centered Healthcare
- SH2. Digital Health Information Infrastructure
- SH3. From Data to Decisions
- SH4. Interoperability of Health Record Systems, Medical Sensors, Devices and Robotics
- BM1. Pharmaceutical Manufacturing
- BM2. Materials for Biomedical Applications
- BM3. Biomedical Engineering
- BM4. Noninvasive Imaging of Brain Function
- BM5. Medical Imaging Technologies
- BM6. Diagnostic Assays and Platforms
- BM7. Drug Delivery
To discuss these opportunities or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!